New Drug Stimulates Immune System to Kill Infected Cells in in an Animal Model of Hepatitis B Infection
Friday, April 26, 2013 - 15:00
in Health & Medicine
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.